93048-16-9

Usage

Uses

Used in Pharmaceutical Industry:
4-Methoxy-2-methylphenylhydrazine hydrochloride is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of bioactive molecules and drugs.
Used in Organic Chemistry:
4-Methoxy-2-methylphenylhydrazine hydrochloride is used as a reagent in chemical reactions, facilitating the formation of desired products and aiding in the advancement of organic synthesis techniques.
Used in Medicinal Chemistry Research:
4-Methoxy-2-methylphenylhydrazine hydrochloride is used as a research tool in medicinal chemistry studies, enabling scientists to explore its potential applications and interactions with biological systems for the discovery of new therapeutic agents.

InChI:InChI=1/C8H12N2O.ClH/c1-6-5-7(11-2)3-4-8(6)10-9;/h3-5,10H,9H2,1-2H3;1H

Upstream product

• 102-50-1 2-methyl-4-methoxyaniline 
• 154876-10-5 1-(4-methoxy-2-methylphenyl)-1,2-hydrazinedicarboxylic acid bis(2,2,2-trichloroethyl) ester 
• 133985-88-3 4-methoxy-2-methyl-aniline; hydrochloride 

Downstream Products

• 170142-38-8 7-Chloro-4-hydroxy-2-(4-hydroxy-2-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione 
• 170142-29-7 7-Chloro-4-hydroxy-2-(4-methoxy-2-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione sodium salt 
• 1384865-99-9 C₂₀H₂₀N₃O₂⁽¹⁺⁾*Cl^(1-) 

Relevant academic research and scientific papers

Pyridazino quinoline compounds

The invention relates to pyridazinoquinoline compounds of the formulas B and B′ wherein Ring A is selected from an ortho fused aromatic or heteroaromatic five- or six-membered ring and R1, R3and R4are substituents selected from halo, OH, OCF3, NO2, CN, NR′R″, SO2NR′R″, SOmR′alkyl, and a variety of alkyl, aryl, heterocyclic and heteroaryl groups, to pharmaceutical compositions containing them and to methods utilizing them for the treatment of neurological disorders.

Pyridazino quinoline compounds

The present invention relates to compounds, pharmaceutical compositions and methods of using compounds of formula II in the treatment and/or prevention of certain diseases or conditions. In formula II A is chosen from ortho substituted aryl or heteroaryl

Pyridazion quinoline compounds

The present invention relates to compounds, pharmaceutical compositions and methods of using compounds of formula (I) in the treatment and/or prevention of certain diseases or conditions. In formula (I), A is chosen from ortho substituted aryl or heteroaryl species, X is chosen from --OH, --SH, NHR and R 1 or R 2 is chosen from --(CH 2) n L wherein L may be selected from a variety of substituents including aryl, heteroaryl and heterocyclic groups. The compounds are useful in treating and/or preventing neurological disorders associated with excitatory amino acids. STR1

The synthesis of phenylhydrazines from bis(2,2,2-trichloroethyl) azodicarboxylates and electron-rich arenes

Phenylhydrazines are readily prepared in a two step sequences using electron rich arenes molecules and bis(2,2,2 trichloroethyl) azodicarboxylate (BTCEAD).

Tetrahydroindenoindole compounds useful in the treatment of conditions associated with free radical formation

The invention concerns compounds and their enantiomers of the formula IA or IB STR1 and pharmaceutically acceptable salts thereof wherein each of R1, R2, R3, R4, R6, R7, R8, R9, R10, R11 and R12 is independently selected from hydrogen or an alkyl group containing 1-6 carbon atoms and R5 is an alkoxy group containing 1-6 carbon atoms. The invention further concerns pharmaceutical compositions comprising the active compounds and methods employing the compounds for the treatment of conditions associated with free radical formation.

Synthesis of 1,3-dihydro-3,3-dimethyl-2H-indol-2-one derivatives as possible nonsteroidal cardiotonics

New substituted 1,3-dihydro-3,3-dimethyl-2H-indol-2-one derivatives 19-29 and 34-43 were synthesized and examined for their inotropic activity in isolated dog ventricular tissues. Among them, compound 26 (2-(2,3-dimethoxybenzylamino)-N-(3,3,7-trimethyl-2-oxo-2,3-dihydro-1H-i ndol-5-yl)acetamide) showed very potent activity.